SALT LAKE CITY - Recursion, a clinical stage company specializing in drug discovery technology, has announced the appointment of Robert Hershberg, M.D., Ph.D., as the new Chair of the Board. Dr.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback